These ads falsely claim compounded medicines are identical to FDA-approved brands, even though the FDA has not evaluated the products or their active ingredientswhich most American consumers dont know
Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients
Animal Studies: Strong Results in Obese Rodent Models The foundational animal work was conducted in obese Zucker rats and ob/ob mice, two standard models for studying obesity
ATTAIN-1 (NCT05869903) The key trial for the obesity indication, ATTAIN-1 randomized 3,127 adults with obesity or overweight (without diabetes) to orforglipron 6 mg, 12 mg, or 36 mg versus placebo for 72 weeks
The most frequently reported benefits across a variety of diseases included improvement in disease symptoms (45.5%), improved sense of well-being (28.8%), decreased frequency of sinus infections (27.3%), and improved energy (24.2%)
PMC review